News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cesca Therapeutics Announces Pricing Of Public Offering Of Common Stock And Warrants


6/13/2014 8:22:59 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

RANCHO CORDOVA, Calif., June 13, 2014 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (Nasdaq:KOOL), an autologous cell-based regenerative medicine company, announced today the pricing of an underwritten public offering of 7,530,000 Units, consisting of an aggregate of 7,530,000 shares of the Company's common stock and warrants to purchase 2,259,000 shares of the Company's common stock, at a price of $1.50 per Unit. Each warrant entitles the holder to purchase 0.30 of a share of common stock. The warrants will be exercisable immediately upon issuance at an exercise price of $1.55 per share and will expire five years from the date of issuance. The shares of common stock and warrants comprising the Units are immediately separable. All of the Units in the offering are being sold by Cesca. The gross proceeds to Cesca from this offering are expected to be approximately $11.3 million, excluding any future proceeds from the potential exercise of the warrants and before deducting underwriting discounts and commissions and other estimated offering expenses payable by Cesca. The offering is expected to close on or about June 18, 2014, subject to the satisfaction of customary closing conditions.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES